#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation
Click to read this study in The Lancet Oncology.
Click to read this study in The Lancet Oncology.
Click to read this study in JAMA Network Open.
1. In this randomized controlled trial, religious psychotherapy was associated with significant improvements in disease perception in Iranian breast cancer ...
Christian Orthodox Church fasting may improve metabolic syndrome risk factors 1. In this scoping review, Christian Orthodox Church (COC) fasters ...
1. In patients with pathological complete response to neoadjuvant systemic therapy, there was no tumour recurrence at 2 years 2. ...
Click to read this study in the Journal of Clinical Oncology.
Click to read this study in the Journal of Clinical Oncology.
1. Some CHEK2 alleles were shown to have a high-risk association of breast cancer compared to other alleles that were ...
1. 25.8% of patients receiving chemotherapy for breast cancer experienced worsening frailty status. 2. Patients with both biomarkers (IL-6 and ...
1. In this retrospective study conducted in the United States, Black women were found to have a higher 5-year breast ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.